Landmark study seeks better paths for lymphoma patients too frail for standard care
NCT ID NCT07335120
Summary
This study aims to collect real-world information on how doctors treat patients with large B-cell lymphoma who are too frail for standard, full-dose chemotherapy or whose cancer has returned after initial treatment. By gathering data and samples from 800 patients, researchers hope to better understand the disease and identify which treatment approaches work best for these specific groups. The goal is to use this knowledge to guide future research and improve patient outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DLBCL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Clatterbridge Cancer Centre NHS Foundation Trust
RECRUITINGLiverpool, Merseyside, L78YA, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.